| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.3M | +0.0% |
| R&D Expense | $6.3M | -29.5% |
| SG&A Expense | $6.5M | -23.4% |
| Operating Income | -$12.8M | +18.9% |
| Interest Expense | $2.6M | +27.0% |
| Pre-tax Income | -$15.9M | -412.9% |
| Income Tax | $3.2M | — |
| Net Income | -$19.1M | -445.8% |
| EPS (Basic) | -$0.48 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Short-term Investments | $3.4M | -94.0% |
| Current Assets | $143.2M | -11.9% |
| Total Assets | $155.3M | -29.6% |
| Current Liabilities | $5.7M | -89.3% |
| Stockholders' Equity | $146.3M | -10.7% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$8.4M | +18.3% |
| Capital Expenditures | $18K | -92.9% |
| Investing Cash Flow | $105.8M | +244.9% |
| Financing Cash Flow | -$52.0M | -200.1% |
| Free Cash Flow | -$8.4M | +20.1% |
| -442.9% |
| EPS (Diluted) | -$0.48 | -442.9% |